Navigation Links
MRSA study demonstrates need for frequent hand washing and environmental disinfection in health care settings

A major cause of hospital-acquired infections can persist for days and even weeks on environmental surfaces found in healthcare settings, including bed linens, computer keyboard covers and acrylic fingernails, according to research presented today at the 105th General Meeting of the American Society for Microbiology.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections in the United States. Staphylococcal infections can cause conditions ranging from mild skin infections to serious surgical wound infections, pneumonia or blood infections.

"The potential of MRSA to be transferred from person to person, in large part, depends on its ability to survive on environmental surfaces," says researcher Kris Owens of Ecolab, Inc. in Mendota Heights, Minnesota.

For the study, two strains of MRSA were inoculated in triplicate onto coupons made of bed linen, keyboard covers and acrylic fingernails. At selected times over 8 weeks, the coupons were subcultured and surviving bacteria were counted. MRSA survivors remained at detectable levels for 8 weeks on acrylic fingernails, 6 weeks on computer keyboard covers and 5 days on bed linen. "The results of this study clearly demonstrate the need for frequent hand washing and environmental disinfection in health care settings," says Owens.


'"/>

Source:ASM


Page: 1

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
Breaking Biology Technology: